BCom BComm - CSL Chief Officer
| CSJ Stock | EUR 166.44 1.00 0.60% |
Insider
BCom BComm is Chief Officer of CSL Limited
| Age | 57 |
| Phone | 61 3 9389 1911 |
| Web | https://www.csl.com.au |
CSL Management Efficiency
The company has return on total asset (ROA) of 0.0631 % which means that it generated a profit of $0.0631 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1338 %, meaning that it generated $0.1338 on every $100 dollars invested by stockholders. CSL's management efficiency ratios could be used to measure how well CSL manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jens Holstein | BioNTech SE | 60 | |
| Ray Jordan | Moderna | N/A | |
| Noubar Afeyan | Moderna | 60 | |
| Sabine Kohleisen | Mercedes Benz Group AG | 59 | |
| Karsten Knudsen | Novo Nordisk AS | 52 | |
| MD FASN | Vertex Pharmaceuticals Incorpor | 50 | |
| Ourania Tatsis | Vertex Pharmaceuticals Incorpor | 52 | |
| Thomas Laubert | Mercedes Benz Group AG | 50 | |
| Tracey Franklin | Moderna | 39 | |
| Kristen Ambrose | Vertex Pharmaceuticals Incorpor | 46 | |
| Paul Sagan | Moderna | 59 | |
| Ryan Richardson | BioNTech SE | 44 | |
| Stephen Hoge | Moderna | 42 | |
| Tal Zaks | Moderna | 53 | |
| Camilla Sylvest | Novo Nordisk AS | 51 | |
| Elizabeth Tallett | Moderna | 70 | |
| Ludovic Helfgott | Novo Nordisk AS | 49 | |
| Sean Marett | BioNTech SE | 58 | |
| Henrik Wulff | Novo Nordisk AS | 53 | |
| Jorg Burzer | Mercedes Benz Group AG | 53 | |
| John Reynders | Moderna | N/A | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0631 |
CSL Limited Leadership Team
Elected by the shareholders, the CSL's board of directors comprises two types of representatives: CSL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CSL. The board's role is to monitor CSL's management team and ensure that shareholders' interests are well served. CSL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CSL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BCom BComm, Chief Officer | ||
| Paul McKenzie, Chief Officer | ||
| Christina Hickie, Sr Communications | ||
| Wilfried Freudenberg, Department Production | ||
| BS BS, Exec Counsel | ||
| MS BA, Ex Officer | ||
| Paul BA, CEO MD | ||
| Karen Etchberger, Exec Services | ||
| Jemimah Brennan, Head Pacific | ||
| Mark Dehring, Head Relations |
CSL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CSL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0631 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 91.69 B | |||
| Shares Outstanding | 482.22 M | |||
| Shares Owned By Insiders | 0.41 % | |||
| Shares Owned By Institutions | 35.53 % | |||
| Price To Earning | 35.97 X | |||
| Price To Book | 6.69 X |
Currently Active Assets on Macroaxis
Other Information on Investing in CSL Stock
CSL financial ratios help investors to determine whether CSL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.